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Abstract: Studies have reported controversial findings on the association between fetal growth
restriction (FGR) or intertwin weight discordance and the risk of hypertensive disorders of pregnancy
(HDP) in twin pregnancies. The aim of this study was to investigate the association between
twin growth disorders and HDP. Twin pregnancies resulting in two live births at St George’s
Hospital between 2000 and 2019 were included. FGR or small-for-gestational-age (SGA) at birth was
assessed using singleton and twin reference charts. Intertwin discordance [(large birthweight − small
birthweight)/(large birthweight) × 100%)] was calculated. Logistic regression models were performed.
SGA (aOR 2.34, 95% CI 1.60–3.44, p < 0.001), intertwin discordance ≥25% (aOR 2.10, 95% CI 1.26–3.49,
p = 0.004) and their co-existence (aOR 2.03, 95% CI 1.16–3.54, p = 0.013) were significantly associated
with HDP. After adjusting for the known maternal risk factors of HDP and the intertwin discordance,
SGA (using the twin charts) was the strongest independent risk factor associated with HDP (aOR
2.12, 95% CI 1.40–3.22, p < 0.001) and preeclampsia (aOR 2.34, 95% CI 1.45–3.76, p < 0.001). This study
highlights that the presence of at least one SGA twin is significantly associated with HDP during
pregnancy. Therefore, maternal blood pressure should be closely monitored in twin pregnancies
complicated by SGA with or without intertwin discordance.
Keywords: preeclampsia; hypertensive disorders of pregnancy; twin pregnancy; fetal growth
restriction; small for gestational age; birthweight discordance
1. Introduction
The rising age at childbirth and the extensive use of fertility enhancing treatments have contributed
to the increased incidence of twin pregnancies [1]. Many pregnancy complications are more commonly
encountered in multiple pregnancies than in singletons, including hypertensive disorders of pregnancies
(HDP), the incidence of which is at least two times higher, in both dichorionic and monochorionic twin
pregnancies [2,3]. A common fetal complication of twin pregnancies is small for gestational age (SGA),
defined as birthweight <10th percentile [4]. Even in the absence of SGA, twin pregnancies can be
complicated by large intertwin birthweight discordance. Although the cause and pathophysiology of
increased intertwin discordance are not fully understood, this condition is associated with an increased
risk of adverse perinatal mortality and morbidity [5,6].
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Whereas the association between fetal growth anomalies and HDP has been well established
in singleton pregnancies [7], several studies investigating this relationship in twin pregnancies
have reported conflicting results [8–13]. Despite previous negative findings [10,11], Proctor et al.
demonstrated that the association between SGA and HDP in dichorionic twin pregnancies seems to
be similar to that observed in singleton pregnancies when twin-specific birthweight references were
used [8]. Moreover, a recent report has shown that discordant twins had a higher risk of preeclampsia,
with a positive correlation with the degree of intertwin weight discordance [9].
We are yet to ascertain whether twin pregnancies complicated by fetal growth abnormalities
are at increased risk of HDP or preeclampsia, and whether any such association differs according
to chorionicity.
2. Experimental Section
2.1. Study Population
This was a cohort study with retrospective analysis of prospectively collected data. The inclusion
criteria were unselected twin pregnancies with two live births at St George’s Hospital, London,
UK, between January 2000 and January 2019. Pregnancies were identified by searching the
electronic maternity records (ViewPoint version 5.6.26.148, ViewPoint Bildverarbeitung GMBH,
Wessling, Germany). Exclusion criteria were major fetal structural anomalies or aneuploidy,
twin-to-twin transfusion syndrome (TTTS), twin reversed arterial perfusion sequence (TRAPS),
twin anemia-polycythemia sequence (TAPS), missing gestational age at delivery, birthweight or HDP
data, and women with pre-pregnancy hypertension. Pregnancy outcomes were ascertained from the
maternity database and neonatal records.
2.2. Study Variables and Outcomes
Data on maternal age in years, weight in kilograms, body mass index (BMI) in kg/m2, reported
ethnicity, mode of conception and smoking were collected. The chorionicity was determined based on the
number of placentas and the presence or absence of the lambda sign at the intertwin membrane–placenta
junction, as well as the intertwin membrane thickness at the site of its insertion in the chorion at
11–14 weeks, or the number of placentas and the fetal gender after 14 weeks’ gestation [14–16].
Gestational age (GA) was determined according to the crown-rump length (in the first trimester) or
head circumference (after 14 weeks’ gestation) of the larger fetus in cases of spontaneous conception
and according to the timing of in vitro fertilization for pregnancies conceived via assisted reproductive
technology [14,17–19].
Intertwin birthweight discordance was calculated using the following formula: [(larger twin
Birthweight − smaller twin Birthweight)/(larger twin Birthweight) × 100%)]. Three different cut-offs
(≥15%, ≥20% and ≥25%) were used to define a significant intertwin birthweight discordance [6]. SGA
was defined as birthweight centile below the 10th centile and fetal growth restriction (FGR) was defined
as birthweight centile of one of the fetuses below the 3th centile [3]. Although the recent Delphi
consensus statement did not propose a definition for selective fetal growth restriction (sFGR) at birth,
we adapted the antenatal criteria of one of the following: (1) one twin below the 10th birthweight
centile and a birthweight discordance of more than 25% or (2) the solitary criterion of one twin with
FGR [20]. The birthweight centiles were assessed using the singleton standard reported by Poon et al.
and twin chorionicity specific standards reported by Ananth et al. [16,21].
HDP included gestational hypertension and preeclampsia, as defined by the International
Society for the Study of Hypertension in Pregnancy (ISSHP) guideline [22]. Women with new-onset
hypertension (≥140mm/Hg systolic or ≥90mm/Hg diastolic on two separate occasions 12 h apart)
were classified as gestational hypertension or preeclampsia according to the presence of systemic
involvement (significant proteinuria or maternal organ dysfunction). Significant proteinuria was
defined as protein/creatinine ratio (PCR) ≥30mg/mmol. Other criteria of systemic involvement
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included liver dysfunction (aspartate aminotransferase or alanine aminotransferase concentrations
more than twice the upper reference range), reduced platelet count (<100,000/µL), hemolysis (increased
lactate dehydrogenase concentration more than twice the upper reference range), renal failure
(creatinine >90 umol/L), or neurological symptoms (persistent severe headache, seizures).
2.3. Statistical Analysis
Categorical data were presented as number (%) and compared using the Fisher’s exact test or
Chi-square test. Continuous data were presented as median (interquartile range, IQR). The D’Agostino
and Pearson Omnibus test was used to assess the normality of the data. Non-parametric analysis
using Mann-Whitney U-test was then used to compare continuous data between the study groups.
We planned a priori sensitivity analysis according to chorionicity (dichorionic and monochorionic).
Logistic regression analyses were used to assess the association between birthweight discordance, FGR
or SGA and HDP or preeclampsia. Both univariate and multivariate logistic regression analyses were
performed, adjusting for known risk factors for preeclampsia. P values below 0.05 were considered
statistically significant. The statistical analysis was performed using SPSS version 26.0 (SPSS, Statistical
Package for the Social Sciences, IBM, NY, USA) and RStudio (Version 1.0.136, Rstudio, Inc., Boston,
MA, USA) statistical software.
3. Results
3.1. Study Population
The analysis included 1473 twin pregnancies, with 152 (10.3%) pregnancies complicated by
HDP and 110 cases of preeclampsia. The comparison of the twin pregnancies according to whether
they developed HDP or not is presented in Table 1. Compared with women with normotensive
pregnancies, women in the HDP group were more likely to be nulliparous (67.1% vs. 55.2%, p =
0.005) and had significantly higher BMI (median (IQR) 25.7 (22.3–29.7) kg/m2 vs. 24.3kg/m2 (21.8–27.8),
p = 0.009). When compared to normotensive twin pregnancies, those complicated by HDP delivered
at a significantly earlier gestation (median (IQR) 36.1 (34.6–37.1) weeks vs. 36.9 (35.0–37.6) weeks,
p < 0.001), were more likely to be admitted to the High Dependency Unit (HDU) or Intensive Care
Unit (ICU) (19.1% vs. 4.4%, p < 0.001), and their babies more likely to be admitted to the neonatal unit
(NNU) (38.8% vs. 30.7%, p = 0.040). They were also more likely to have both neonates small, whether
as SGA (7.9% vs. 2.9%, p = 0.001) or FGR (3.3% vs. 0.5%, p < 0.001). A total of 176 cases of sFGR were
identified: 33 (21.7%) in the HDP group and 143 (10.8%) in the control group (p < 0.001).
3.2. The Association of Intertwin Birthweight Discordance and FGR in Twin Pregnancies with HDP
The median (IQR) intertwin birthweight discordance was significantly greater in the HDP group
when compared to the normotensive pregnancies (12.9%; 4.8–19.5 vs. 9.3%; 4.1-16.0, p = 0.003).
Intertwin discordance ≥15% (44.7% vs. 28.3%, p < 0.001), ≥20% (25.0% vs. 17.3%, p = 0.019), ≥25%
(15.8% vs. 8.1%, p = 0.002) were significantly more common in the HDP group compared to the
normotensive group (Table 2). The results of the logistic regression analysis are shown in Table 2. The
association between intertwin discordance and HDP remained significant even after adjusting for
maternal age, BMI, parity, assisted conception and gestational age at delivery (Table 2).
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Table 1. Baseline characteristics of twin pregnancies complicated by hypertensive disorders of
pregnancy (HDP) compared to normotensive twin pregnancies.
Normotensive
Pregnancies (n = 1321)
Pregnancies with HDP
(n = 152) p Value
Maternal age in years, median (IQR) 33 (30–36) 34 (31–37) 0.227
Maternal body mass index in kg/m2, median (IQR) 24.3 (21.8–27.8) 25.7 (22.3–29.7) 0.009
Maternal weight in kg, median (IQR) 66.1 (59.5–76.0) 69.5 (61.7–80.7) 0.004
Nulliparous, n (%) 729 (55.2) 102 (67.1) 0.005
Racial origin, n (%)
0.914
• Caucasian 733 (59.9) 93 (63.3)
• Afro-Caribbean 195 (15.9) 21 (14.3)
• Asian 148 (12.1) 15 (10.2)
• Mixed 13 (1.1) 2 (1.4)
• Others 134 (11) 16 (10.9)
Smokers, n (%) 68 (5.3) 7 (4.9) 0.821
Assisted conception, n (%) 359 (27.4) 52 (34.2) 0.072
Chorionicity, n (%)
0.107• Dichorionic 1048 (79.3) 129 (84.9)
• Monochorionic 273 (20.7) 23 (15.1)
Gestational age at delivery in weeks, median (IQR) 36.9 (35.0–37.6) 36.1 (34.6–37.1) <0.001
Admission to HDU/ICU, n (%) 58 (4.4) 29 (19.1) <0.001
Larger twin birthweight in grams, median (IQR) 2560 (2205–2850) 2482 (2058–2830) 0.106
Smaller twin birthweight in grams, median (IQR) 2300 (1930–2560) 2100 (1733–2455) 0.001
Larger twin birthweight centile, median (IQR)
(a) Twin standard 54.1 (34.5–74.6) 51.0 (29.0–71.4) 0.1
(b) Singleton standard 31.4 (15.3–52.1) 29.7 (15.5–50.6) 0.734
Smaller twin birthweight centile, median (IQR)
(a) Twin standard 27.2 (11.4–47.9) 8.3 (5.9–40.0) <0.001
(b) Singleton standard 10.6 (3.2–23.9) 6.3 (1.8–19.2) 0.002
Admission to NNU, n (%) 405 (30.7) 59 (38.8%) 0.04
Larger twin admitted to NNU, n (%) 335 (25.7) 47 (30.9) 0.128
Smaller twin admitted to NNU, n (%) 358 (27.1) 55 (36.2) 0.018
Abbreviations: HDU: High Dependency Unit; ICU: Intensive Care Unit; NNU: Neonatal Unit.
Table 2. The association between intertwin birthweight discordance and HDP.
Normotensive
Pregnancies
(n = 1321)
Pregnancies
with HDP
(n = 152)
Unadjusted
OR
(95% CI)
p Value
Adjusted
OR
(95% CI) *
p Value
Intertwin birthweight
discordance ≥15%, n (%) 374 (28.3) 68 (44.7)
2.05
(1.46–2.88) <0.001
2.57
(1.69–3.91) <0.001
Intertwin birthweight
discordance ≥20%, n (%) 228 (17.3) 38 (25.0)
1.60
(1.08–2.37) 0.020
1.77
(1.09–2.88) 0.020
Intertwin birthweight
discordance ≥25%, n (%) 107 (8.1) 24 (15.8)
2.13
(1.32–3.43) 0.002
2.10
(1.26–3.49) 0.004
* Adjustment for body mass index, parity and gestational age at delivery. Abbreviations: OR: odds ratio; CI:
confidence interval.
The association between fetal growth disorders and HDP in twin pregnancies was stronger
when twin standard birthweight charts were used rather than the singleton equivalent (Table 3). The
prevalence of SGA of at least one twin (40.1% vs. 23.1%, p < 0.001; aOR = 2.34, 95% CI: 1.60–3.44,
p < 0.001) and FGR of at least one twin (17.1% vs. 8.7%, p = 0.001; aOR = 2.17, 95% CI: 1.29-3.64,
p = 0.004), defined by twin standard birthweight charts, were significantly higher in hypertensive
than in normotensive pregnancies. The co-presence of SGA affecting at least one twin and intertwin
discordance ≥25% was also significantly associated with HDP (aOR = 2.03, 95% CI: 1.16-3.53, p = 0.013).
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Table 3. The association between intertwin birthweight discordance, fetal growth restriction (FGR)
and HDP.
Normotensive
Pregnancies
(n = 1321)
Pregnancies
with HDP
(n = 152)
Unadjusted
OR
(95% CI)
p Value
Adjusted
OR
(95% CI) *
p Value
Twin standards
SGA in at least one twin,
n (%) 305 (23.1) 61 (40.1)
2.23
(1.58–3.16) <0.001
2.34
(1.60–3.44) <0.001
FGR in at least one twin,
n (%) 115 (8.7) 26 (17.1)
2.16
(1.36–3.44) 0.001
2.17
(1.29–3.64) 0.004
SGA in at least one twin
plus Intertwin
birthweight discordance
≥25%, n (%)
93 (7.0) 20 (13.2) 2.00(1.19–3.35) 0.008
2.03
(1.16–3.53) 0.013
Singleton standards
SGA in at least one twin,
n (%) 642(48.6) 94 (61.8)
1.71
(1.21–2.42) 0.002
1.89
(1.30–2.75) 0.001
FGR in at least one twin,
n (%) 320 (24.2) 48 (31.6)
1.44
(1.00–2.08) 0.048
1.40
(0.94–2.07) 0.094
SGA in at least one twin
plus Intertwin
birthweight discordance
≥25%, n (%)
101 (7.6) 23 (15.1) 2.15(1.32–3.51) 0.002
2.15
(1.28–3.61) 0.004
* Adjustment for body mass index, parity and gestational age at delivery. Abbreviations: SGA: small for gestational
age; FGR: fetal growth restriction; OR: odds ratio; CI: confidence interval.
The sensitivity analysis according to the chorionicity is shown in Table 4. These associations
between intertwin discordance or FGR and HDP remained statistically significant for dichorionic but
not for monochorionic twin pregnancies.
Table 4. The association between intertwin weight discordance, fetal growth restriction and hypertensive
disorders of pregnancy, stratified by chorionicity.
Normotensive
Pregnancies
(n = 1321)
Pregnancies
with HDP
(n = 152)
p Value OR(95% CI) p Value
Dichorionic twin pregnancies
Birthweight discordance ≥25%,
n (%) 77 (7.3) 21 (16.3) 0.001 2.45 (1.45–4.13) 0.001
SGA in at least one twin, n (%) 243 (23.2) 52 (40.3) <0.001 2.24 (1.53–3.27) <0.001
FGR in at least one twin, n (%) 84 (8.0) 21 (16.3) 0.002 2.23 (1.33–3.75) 0.002
SGA in at least one twin plus
Intertwin birthweight
discordance ≥25%, n (%)
65 (6.2) 17 (13.2) 0.003 2.29 (1.3–4.05) 0.004
Monochorionic twin pregnancies
Birthweight discordance ≥25%,
n (%) 30 (11.0) 3 (13.0) 0.730 1.21 (0.34–4.33) 0.764
SGA in at least one twin, n (%) 62 (22.7) 9 (39.1) 0.077 2.19 (0.90–5.29) 0.083
FGR in at least one twin, n (%) 31 (11.4) 5 (21.7) 0.143 2.17 (0.75–6.25) 0.152
SGA in at least one twin plus
Intertwin birthweight
discordance ≥25%, n (%)
28 (10.3) 3 (13.0) 0.720 1.31 (0.37–4.70) 0.676
Abbreviations: SGA: small for gestational age; FGR: fetal growth restriction; HDP: hypertensive disorders of
pregnancy; OR: odds ratio; CI: confidence interval.
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3.3. The Association of Intertwin Birthweight Discordance and FGR with HDP or Preeclampsia after
Adjustment for the Known Risk Factors for Preeclampsia
Maternal age, BMI and nulliparity, SGA in at least one twin and intertwin birthweight discordance
≥25% were significantly associated with HDP in the univariate logistic regression (Table 5). However,
only BMI (OR 1.06, 95% CI 1.02–1.09, p = 0.001), nulliparity (OR 1.81, 95% CI 1.23–2.68, p = 0.003)
and SGA in at least one twin (OR 2.12, 95% CI 1.40–3.22, p < 0.001) remained significantly associated
with HDP in the multivariate analysis. When the analysis was limited to pregnancies complicated
by preeclampsia, SGA in at least one twin (OR 2.34, 95% CI 1.45–3.76, p < 0.001), BMI (OR 1.05, 95%
CI 1.01–1.09, p = 0.007) and nulliparity (OR 1.74, 95 CI 1.10–2.74, p = 0.017) were associated with
preeclampsia in the multivariate logistic regression analysis.
Table 5. Univariate and multivariate logistic regression analysis to identify which maternal and fetal
factors are associated with hypertensive disorders of pregnancy and preeclampsia.
Univariable Analysis Multivariable Analysis
OR (95% CI) p Value OR (95% CI) p Value
Hypertensive disorders of pregnancy (n = 152)
Maternal age in years 1.03 (1.00–1.06) 0.045 1.03 (1.00–1.07) 0.035
Maternal body mass index in kg/m2 1.04 (1.01–1.08) 0.009 1.06 (1.02–1.09) 0.001
Assisted conception 1.39 (0.97–1.98) 0.073 — —
Nulliparous 1.66 (1.16–2.36) 0.005 1.81 (1.23–2.68) 0.003
SGA in at least one twin (twin standards) 2.23 (1.58–3.16) <0.001 2.12 (1.40–3.22) <0.001
Intertwin birthweight discordance ≥25% 2.13 (1.32–3.43) 0.002 1.34 (0.76–2.36) 0.307
Preeclampsia (n = 110)
Maternal age in years 1.01 (0.98–1.05) 0.467 – –
Maternal body mass index in kg/m2 1.04 (1.00–1.08) 0.047 1.05 (1.01–1.09) 0.007
Assisted conception 1.39 (0.92–2.20) 0.113 – –
Nulliparous 1.72 (1.14–2.61) 0.010 1.74 (1.10–2.74) 0.017
SGA in at least one twin (twin standards) 2.44 (1.64–3.64) <0.001 2.34 (1.45–3.76) <0.001
Intertwin weight discordance ≥25% 2.33 (1.37–3.96) 0.002 1.47 (0.79–2.72) 0.224
Abbreviations: OR: odds ratio; CI: confidence interval; SGA: small for gestational age.
4. Discussion
4.1. Summary of Main Results
Our findings demonstrate that intertwin discordance ≥15%, ≥20%, ≥25%, SGA in at least one
twin and FGR in at least one twin were significantly associated with HDP. This association was
stronger when twin-specific reference birthweight charts were used compared to the use of singleton
charts. The presence of SGA in at least one twin was an independent predictor of the risk of HDP
or preeclampsia, even after adjusting for the known maternal risk factors for preeclampsia and the
intertwin birthweight discordance.
4.2. Interpretation of Study Findings and Comparison with Published Literature
The association between fetal growth disorders and the development of hypertension in twin
pregnancies has been investigated, with evidence of conflicting results [8–13]. In small retrospective
studies, the association between SGA and preeclampsia was not detected. This was primarily because
authors used singleton-based birthweight reference charts to define SGA, leading to a very high rate of
SGA twins in both normotensive and hypertensive twin pregnancies [10,11]. Conversely, SGA was
associated with an increased risk of preeclampsia in studies where a twin-specific birthweight chart
was used [8,12,13]. In our study, SGA and FGR were associated with HDP using either singleton or
twin charts; however, these associations were stronger when twin-specific charts were used. Little is
known about the association between intertwin birthweight discordance and HDP. Qiao et al. recently
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showed that growth discordance, adjusted for SGA, is an independent risk factor for the occurrence of
preeclampsia in twin pregnancies. However, the authors did not specify which reference was used to
calculate birthweight centile [9].
Our results reveal that both intertwin birthweight discordance and either SGA or FGR complicating
a twin pregnancy was associated with HDP or preeclampsia, but the presence of SGA in at least
one twin seems to be the strongest risk factor. These data are consistent with previous studies that
confirmed the association between fetal growth disorders and HDP in dichorionic twin pregnancies.
We could not demonstrate a similar relationship in monochorionic twin pregnancies, which could be
due to the different pathology of growth disorders (unequal placental sharing) or the small sample size.
It is well known that placental insufficiency, which can be manifested as HDP or SGA, is related to
inadequate remodeling of spiral arteries and, subsequently, to a malperfusion of the placenta. However,
there is increasing evidence that placentas from twin pregnancies complicated by preeclampsia, fetal
growth disorders, or both, showed a lower prevalence of histological lesions than those from their
singleton counterparts [23–26]. Moreover, compared with SGA singletons, SGA twins were less likely
to have any placental pathology, including maternal vascular malperfusion pathology (aOR 0.24),
fetal vascular malperfusion pathology (aOR 0.62), hypercoiled cord (aOR 0.45), and placental weight
less than the 10th centile (aOR 0.13). However, SGA twins were more likely to have a marginal or
velamentous cord insertion compared with SGA singletons (aOR 13.82) [24]. Thus, growth disorders
and HDP in twins might be caused by maternal failure to supply the increased demand of two fetuses
rather than merely placental insufficiency. One possible explanation of the difference between twin and
singleton pregnancies in the pathophysiology of FGR and HDP might be the maternal inability to adapt
to and meet the greater placental demand in a twin pregnancy. When the maternal cardiovascular
system fails to adequately supply the uteroplacental unit, placental hypoperfusion might lead to
fetal growth disorders and/or maternal hypertension [27]. Impaired maternal cardiovascular system
reported in conditions such as obesity, chronic hypertension or diabetes can boost this mechanism as
showed by a higher BMI in the HDP group compared to the controls in our cohort [28].
Previous studies demonstrated that chorionicity is not associated with HDP [2,29,30]. However,
monochorionic twin pregnancies seem to be less affected by hypertensive complications compared to
dichorionic ones [2]. This might be due to a lower gestational age at delivery in monochorionic twins [31]
and to a lower circulating blood volume in monochorionic twin pregnancies (single fetal-placental unit)
with a subsequent better cardiovascular adaptation to the pregnancy compared to dichorionic twins
(double fetal-placental unit) [32]. However, more studies are necessary to elucidate the differences
between the two groups and to explain the pathogenesis of HDP in each group.
4.3. Clinical and Research Implications
The use of twin charts could reduce the risk of unnecessary iatrogenic prematurity in twin
pregnancies, as fewer pregnancies are labeled as complicated by FGR [33,34]. Moreover, routine
assessment of fetal Dopplers in these pregnancies is likely to stratify their risk and antenatal management,
in particular the ideal timing of birth.
The association between FGR/SGA and HDP in twins might facilitate early identification of
women at increased risk of developing hypertension during pregnancy. These women are likely to
benefit from closer blood pressure monitoring that can be performed by using different approaches
and tools. For instance, the introduction of telemonitoring system in pregnancies has made the blood
pressure monitoring more accessible and cost-saving [35,36].
4.4. Strengths and Limitations
The main limitation of this study is its retrospective design. We could not identify the timing of
each event during pregnancy as we evaluated the association between growth disorders at birth and
HDP. We excluded pregnancies complicated by stillbirth, which could potentially represent the most
severe end of the spectrum. The lack of data on placental histology in all the pregnancies does not
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allow us to confirm chorionicity or to investigate the association between the placental pathological
findings, HDP and small twins. Other limitations include the lack of a singleton group to compare the
magnitude of this association and the absence of Doppler data in the analysis which help to differentiate
fetuses which are truly growth restricted from those which were constitutionally small.
The main strength is the large sample size, robust diagnostic criteria for FGR/SGA, HDP and
preeclampsia and the comparison of singleton- and twin-based birthweight charts to calculate the
birthweight percentile.
5. Conclusions
This study highlights the association between fetal growth abnormalities and maternal
hypertension in twin pregnancies. Prospective studies are needed to clarify whether closer monitoring
of blood pressure in twin pregnancies with fetal growth abnormalities could facilitate earlier diagnosis
and improve the monitoring and management of HDP, and maternal and perinatal outcomes.
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